355 related articles for article (PubMed ID: 26676102)
1. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network.
Chiesa Fuxench ZC; Shin DB; Ogdie Beatty A; Gelfand JM
JAMA Dermatol; 2016 Mar; 152(3):282-90. PubMed ID: 26676102
[TBL] [Abstract][Full Text] [Related]
2. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
3. Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2015 Nov; 173(5):1183-90. PubMed ID: 26265015
[TBL] [Abstract][Full Text] [Related]
4. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
5. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
[TBL] [Abstract][Full Text] [Related]
6. Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
Shalom G; Zisman D; Bitterman H; Harman-Boehm I; Greenberg-Dotan S; Dreiher J; Feldhamer I; Moser H; Hammerman A; Cohen Y; Cohen AD
JAMA Dermatol; 2015 May; 151(5):533-8. PubMed ID: 25797026
[TBL] [Abstract][Full Text] [Related]
7. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
Dai H; Li WQ; Qureshi AA; Han J
J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
[TBL] [Abstract][Full Text] [Related]
8. The risk of malignancy associated with psoriasis.
Margolis D; Bilker W; Hennessy S; Vittorio C; Santanna J; Strom BL
Arch Dermatol; 2001 Jun; 137(6):778-83. PubMed ID: 11405770
[TBL] [Abstract][Full Text] [Related]
9. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Kalb RE; Fiorentino DF; Lebwohl MG; Toole J; Poulin Y; Cohen AD; Goyal K; Fakharzadeh S; Calabro S; Chevrier M; Langholff W; You Y; Leonardi CL
JAMA Dermatol; 2015 Sep; 151(9):961-9. PubMed ID: 25970800
[TBL] [Abstract][Full Text] [Related]
10. Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.
Takeshita J; Wang S; Shin DB; Mehta NN; Kimmel SE; Margolis DJ; Troxel AB; Gelfand JM
JAMA Dermatol; 2015 Feb; 151(2):161-9. PubMed ID: 25322196
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Exposure, Infection, and the Development of Pediatric Psoriasis: A Nested Case-Control Study.
Horton DB; Scott FI; Haynes K; Putt ME; Rose CD; Lewis JD; Strom BL
JAMA Dermatol; 2016 Feb; 152(2):191-9. PubMed ID: 26560335
[TBL] [Abstract][Full Text] [Related]
12. Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2014 Feb; 170(2):366-73. PubMed ID: 24251402
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cardiovascular risk factors in patients with psoriasis.
Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
[TBL] [Abstract][Full Text] [Related]
14. Risk of myocardial infarction in patients with psoriasis.
Gelfand JM; Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB
JAMA; 2006 Oct; 296(14):1735-41. PubMed ID: 17032986
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
[TBL] [Abstract][Full Text] [Related]
16. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.
Wan J; Wang S; Haynes K; Denburg MR; Shin DB; Gelfand JM
BMJ; 2013 Oct; 347():f5961. PubMed ID: 24129480
[TBL] [Abstract][Full Text] [Related]
17. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.
Brauchli YB; Jick SS; Miret M; Meier CR
Br J Dermatol; 2009 May; 160(5):1048-56. PubMed ID: 19210501
[TBL] [Abstract][Full Text] [Related]
19. Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.
Iskandar IY; Ashcroft DM; Warren RB; Yiu ZZ; McElhone K; Lunt M; Barker JN; Burden AD; Ormerod AD; Reynolds NJ; Smith CH; Griffiths CE
Br J Dermatol; 2015 Aug; 173(2):510-8. PubMed ID: 25989336
[TBL] [Abstract][Full Text] [Related]
20. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
